Stephanie Schonewald will speak on the panel, “Diverging Life Science Patent Standards: What Contrasting European and USPTO Approaches Mean for Global IP Strategy,” on October 14, 2026, at the Life Science Legal Strategy Summit 2026 in Frankfurt, Germany. Stephanie will join fellow panelists to discuss differences between European and U.S. patent doctrines and how those differences affect global intellectual property strategy. The session will address topics including inventive step/non-obviousness, sufficiency/enablement, plausibility and written description, and the implications of differing approaches for patent drafting, prosecution, litigation, and post-grant strategies in the United States and Europe. The Life Science Legal Strategy Summit 2026 brings together legal professionals and industry stakeholders to discuss intellectual property, regulatory, competition, and corporate law issues affecting the life sciences sector. LEARN MORE